Talk:Mesalazine
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Mesalazine.
|
Methaeoglobinaemia
[edit]"Methaeoglobinaemia" is listed as a side effect. Should this be "Methaemoglobinaemia" (with an "m"), which redirects to Methemoglobinemia? Songdog 15:13, 8 March 2006 (UTC)
Mesalamine
[edit]Content moved from mesalamine to mesalazine to reflect the International Nonproprietary Name rather than the United States Approved Name PeteThePill 22:55, 18 Jun 2005 (UTC)
Lialda
[edit]The section describing Lialda sounds a little bit like a sales pitch for the drug. The other formulations are not really mentioned much, and it seems to be emphasizing benefits of Lialda that don't seem proven yet. I'm just a layperson when it comes to this stuff, so please take my comment with a grain of salt. —Preceding unsigned comment added by 198.135.207.129 (talk) 16:19, 17 January 2008 (UTC)
Mode of action?
[edit]How does the drug work? If this is not known, it should be said that such information is unavailable. —Preceding unsigned comment added by 99.238.142.12 (talk) 22:21, 25 August 2008 (UTC)
Asacol is banned now by the FDA and in several countries due to the presence of dibutyl phthalate, I think it is worth mentioning. The ban also suspeciously comes just as the patent was expiring and the new patent for drug Delzicol came. — Preceding unsigned comment added by 117.192.242.244 (talk) 06:01, 30 January 2014 (UTC)
Advert?
[edit]This page supposedly on a generic drug reads like an advert for Apriso — Preceding unsigned comment added by 194.176.105.132 (talk) 17:12, 23 May 2012 (UTC)
- I removed some of the Apriso stuff and reorganized some of the content. -- Ed (Edgar181) 20:32, 24 May 2012 (UTC)
"PENTASA" listed at Redirects for discussion
[edit]An editor has asked for a discussion to address the redirect PENTASA. Please participate in the redirect discussion if you wish to do so. Whywhenwhohow (talk) 02:22, 10 December 2019 (UTC)